Inflection Phase is a global consultancy for the biotechnology and pharmaceutical industry. The company focuses on strategies to maximize value inflection points during the product lifecycle. By combining in-house and externally-partnered expertise, Inflection Phase delivers comprehensive core competencies in regulatory science, from formulating translational proof-of-concept (POC) strategies through to expansion of existing therapies into emerging markets.